To inform the development of a successor to the national drugs strategy, the Department of Health convened a series of targeted in-person consultations with key stakeholders. The intention of these consultations was to complement the recommendations of the Citizens Assembly on Drugs Use and the separate independent evaluation of the existing national drugs strategy. The consultations followed six themes, with the events being held in the Department of Health’s premises to minimise costs. The Department of Health sought the professional services of a facilitator to design, facilitate and report on consultation events with key stakeholders, over a period of weeks from the start of January to early April 2025, on learning from the current strategy and priority issues/themes to support the development of a successor to the current national drug strategy. They awarded the tender to independent facilitators Dr Grainne Healy and Dr Kathy Walsh.